Fulgent Genetics (FLGT) Total Current Liabilities (2016 - 2026)
Fulgent Genetics' Total Current Liabilities history spans 12 years, with the latest figure at $90.1 million for Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 36.74% to $90.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $90.1 million, a 36.74% increase, with the full-year FY2025 number at $85.0 million, up 16.55% from a year prior.
- Total Current Liabilities hit $90.1 million in Q1 2026 for Fulgent Genetics, up from $85.0 million in the prior quarter.
- Over the last five years, Total Current Liabilities for FLGT hit a ceiling of $141.7 million in Q1 2022 and a floor of $61.4 million in Q3 2023.
- Historically, Total Current Liabilities has averaged $83.8 million across 5 years, with a median of $75.8 million in 2024.
- Biggest five-year swings in Total Current Liabilities: plummeted 49.17% in 2023 and later soared 36.74% in 2026.
- Tracing FLGT's Total Current Liabilities over 5 years: stood at $88.1 million in 2022, then dropped by 17.13% to $73.0 million in 2023, then decreased by 0.16% to $72.9 million in 2024, then grew by 16.55% to $85.0 million in 2025, then grew by 6.08% to $90.1 million in 2026.
- Business Quant data shows Total Current Liabilities for FLGT at $90.1 million in Q1 2026, $85.0 million in Q4 2025, and $72.4 million in Q3 2025.